Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 67 Lung Neoplasms 29 Brain Neoplasms 11 Head and Neck Neoplasms 10 Neoplasms 9 Esophageal Neoplasms 9 Breast Neoplasms 8 Adenocarcinoma of Lung 8 Adenocarcinoma Of Esophagus 7 Glioblastoma 6 Gliosarcoma 5 Esophageal Squamous Cell Carcinoma 5 NSCLC 4 Central Nervous System Neoplasms 4 Adenocarcinoma, Bronchiolo-Alveolar 4 Squamous Cell Carcinoma of Head and Neck 3 Rectal Neoplasms 3 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Stomach Neoplasms 2 Osteosarcoma 2 Oligodendroglioma 2 Neuroblastoma 2 Lymphoid Interstitial Pneumonia 2 Laryngeal Diseases 2 Glioma 2

Interventions

Etoposide 10 Cisplatin 9 Cyclophosphamide 7 etoposide phosphate 5 Paclitaxel 5 Ifosfamide 5 Granulocyte Colony-Stimulating Factor 5 Carboplatin 5 fludarabine 4 Sirolimus 4 Gemcitabine 4 pembrolizumab 3 fludarabine phosphate 3 Sunitinib 3 Mesna 3 Melphalan 3 Filgrastim 3 Drug Therapy 3 Brentuximab Vedotin 3 Bleomycin 3 Bevacizumab 3 Automobiles 3 tremelimumab 2 sodium thiosulfate 2 pegfilgrastim 2 lutetium Lu 177 dotatate 2 durvalumab 2 Vorinostat 2 Stem Cell Transplantation 2 Oxaliplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasms, Germ Cell and Embryonal × Gefitinib × Clear all

NCT00198159 2014-09-19

IUCRO-0021

Indiana University

Phase 2 Terminated

Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡